Featured Research

from universities, journals, and other organizations

That 'Four Hour Erection': Discovery May Help Prevent Complication Of Priapism

Date:
October 26, 2009
Source:
Federation of American Societies for Experimental Biology
Summary:
For men coping with painful erections lasting for long periods of time, or priapism, new research offers hope. That's because researchers show that the enzyme adenosine deaminase may prevent priapism from progressing to penile fibrosis, a condition associated with the build up of scar tissue and eventual impotence. Penile fibrosis is a complication of priapism and priapism is a complication of sickle cell disease.

For men coping with painful erections lasting for long periods of time, or priapism, new research published online in The FASEB Journal offers hope.

That's because researchers from the United States and China show that the enzyme adenosine deaminase may prevent priapism from progressing to penile fibrosis, a condition associated with the build up of scar tissue and eventual impotence. As penile fibrosis is a complication of priapism, so priapism is a complication of sickle cell disease. Adenosine deaminase, which breaks down adenosine, is already used in humans as a treatment for a rare immune disorder.

"Coping with priapism is hard enough, but knowing that it can ultimately lead to fibrosis within the penis adds insult to injury," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "Hopefully this discovery can yield new drugs that relieve the excitatory signals sent by adenosine so that these men to get some relief."

For the study, the researchers used two priapism animal models to determine the role of increased adenosine in penile fibrosis, a dangerous problem believed to be caused by priapism. One model was that of adenosine deaminase-deficient mice and the other was sickle cell disease transgenic mice. Both of these sets of mutant mice were treated with the enzyme adenosine deaminase enzymes to lower adenosine levels. After 8 weeks, they found that this enzyme significantly lowered adenosine levels in the penises of both groups of test mice. Reduction of adenosine by these enzymes successfully prevented and corrected penile fibrosis in both sets of mice.

"Because of our study, we have revealed that increased adenosine signaling contributes to the pathogenesis of the progression of priapism to penile fibrosis," said Yang Xia, a scientist involved in the study from the University of Texas-Houston Medical School's Department of Biochemistry and Molecular Biology. "This finding led to a novel therapeutic possibility to treat and prevent this dangerous complication seen in priapic humans by targeting on this signaling pathway in the near future."


Story Source:

The above story is based on materials provided by Federation of American Societies for Experimental Biology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jiaming Wen, Xianzhen Jiang, Yingbo Dai, Yujin Zhang, Yuxin Tang, Hong Sun, Tiejuan Mi, Prasad V. Phatarpekar, Rodney E. Kellems, Michael R. Blackburn, and Yang Xia. Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling. FASEB Journal, 2009; DOI: 10.1096/fj.09-144147

Cite This Page:

Federation of American Societies for Experimental Biology. "That 'Four Hour Erection': Discovery May Help Prevent Complication Of Priapism." ScienceDaily. ScienceDaily, 26 October 2009. <www.sciencedaily.com/releases/2009/10/091026162540.htm>.
Federation of American Societies for Experimental Biology. (2009, October 26). That 'Four Hour Erection': Discovery May Help Prevent Complication Of Priapism. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2009/10/091026162540.htm
Federation of American Societies for Experimental Biology. "That 'Four Hour Erection': Discovery May Help Prevent Complication Of Priapism." ScienceDaily. www.sciencedaily.com/releases/2009/10/091026162540.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins